Bank of Montreal’s Orphazyme A/S ORPH Stock Holding History

Bank of Montreal’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-61,500	Closed	-$160K	–	4378
2021 Q4	$160K	Sell	61,500 -23,082	-27%	-$81.5K	﹤0.01%	3015
2021 Q3	$361K	Buy	84,582 +45,582	+117%	+$235K	﹤0.01%	3047
2021 Q2	$287K	Buy	+39,000	New	+$314K	﹤0.01%	3074

Other funds holding ORPH

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Bank of Montreal's ORPH Position: Q1 2022 in Review

Bank of Montreal sold out of Orphazyme A/S (ORPH) in Q1 2022, closing a stake of 61,500 shares — an estimated $160K sold.

Bank of Montreal first reported a position in ORPH in Q2 2021 and held it in 3 quarters. The position peaked at $361K in Q3 2021. 4 funds tracked by Wall St. Rank hold ORPH as of Q1 2022.

Bank of Montreal reported no remaining Orphazyme A/S position as of Q1 2022 after selling out during the quarter.
Bank of Montreal sold 61,500 Orphazyme A/S shares in Q1 2022, an estimated $160K.
Bank of Montreal first reported a position in Orphazyme A/S in Q2 2021 and held it in 3 quarters.
Bank of Montreal's Orphazyme A/S position peaked at $361K in Q3 2021.
4 funds tracked by Wall St. Rank held Orphazyme A/S as of Q1 2022.

Based on Bank of Montreal's 13F filing for Q1 2022, filed 12 May 2022.